Tranzyme, Inc. (TZYM) Posts Q3 Loss of $0.26
Tweet
Share
E-mailGet Alerts TZYM Hot Sheet
Join SI Premium – FREE
Tranzyme, Inc. (NASDAQ: TZYM) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $2.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Nomad Foods Limited (NOMD) Tops Q2 EPS by 6c; offers guidance
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
